Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule

被引:105
作者
Tang, FY [1 ]
Nguyen, N [1 ]
Meydani, M [1 ]
机构
[1] Tufts Univ, JM USDA, Vasc Biol Lab, Human Nutr Res Ctr Aging, Boston, MA 02111 USA
关键词
green tea; catechins; angiogenesis; vascular endothelial (VE)-cadherin; Akt;
D O I
10.1002/ijc.11325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies have indicated that the consumption of green tea is associated with a reduced risk of developing certain forms of cancer and angiogenesis. The mechanism of inhibition of angiogenesis by green tea or its catechins, however, has not been well-established. Vascular endothelial (VE)-cadherin, an adhesive molecule located at the site of intercellular contact, is involved in cell-cell recognition during vascular morphogenesis. The extracellular domain of VE-cadherin mediates initial cell adhesion, whereas the cytosolic tail binding with beta-catenin is required for interaction with the cytoskeleton and junctional strength. Therefore, the cadherin-catenin adhesion system is implicated in cell recognition, differentiation, growth and migration of capillary endothelium. Using tube formation of human microvascular endothelial cells (HMVEC) in culture as an in vitro model of angiogenesis, we reported that vascular endothelial growth factor (VEGF)induced tube formation is inhibited by anti-VE-cadherin antibody and dose-dependently by green tea catechins. We also demonstrated here that inhibition of tube formation by epigallocatechin gallate (EGCG), one of the green tea catechins, is in part mediated through suppression of VE-cadherin tyrosine phosphorylation and inhibition of Akt activation during VEGF-induced tube formation. These findings indicate that VE-cadherin and Akt, known downstream proteins in VEGFR-2-mediated cascade, are the new-targeted proteins by which green tea catechins inhibit angiogenesis. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:871 / 878
页数:8
相关论文
共 53 条
  • [1] The Akt kinase:: Molecular determinants of oncogenicity
    Aoki, M
    Batista, O
    Bellacosa, A
    Tsichlis, P
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 14950 - 14955
  • [2] FUNCTIONAL-PROPERTIES OF HUMAN VASCULAR ENDOTHELIAL CADHERIN (7B4/CADHERIN-5), AN ENDOTHELIUM-SPECIFIC CADHERIN
    BREVIARIO, F
    CAVEDA, L
    CORADA, M
    MARTINPADURA, I
    NAVARRO, P
    GOLAY, J
    INTRONA, M
    GULINO, D
    LAMPUGNANI, MG
    DEJANA, E
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) : 1229 - 1239
  • [3] CAO Y, 1999, NATURE, P398
  • [4] Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249
  • [5] Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
    Carmeliet, P
    Lampugnani, MG
    Moons, L
    Breviario, F
    Compernolle, V
    Bono, F
    Balconi, G
    Spagnuolo, R
    Oosthuyse, B
    Dewerchin, M
    Zanetti, A
    Angellilo, A
    Mattot, V
    Nuyens, D
    Lutgens, E
    Clotman, F
    de Ruiter, MC
    Gittenberger-de Groot, A
    Poelmann, R
    Lupu, F
    Herbert, JM
    Collen, D
    Dejana, E
    [J]. CELL, 1999, 98 (02) : 147 - 157
  • [6] Mechanisms of angiogenesis and arteriogenesis
    Carmeliet, P
    [J]. NATURE MEDICINE, 2000, 6 (04) : 389 - 395
  • [7] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [8] Inhibition of cultured cell growth by vascular endothelial cadherin (Cadherin-5 VE-cadherin)
    Caveda, L
    MartinPadura, L
    Navarro, P
    Breviario, F
    Corada, M
    Gulino, D
    Lampugnani, MG
    Dejana, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) : 886 - 893
  • [9] Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability
    Corada, M
    Liao, F
    Lindgren, M
    Lampugnani, MG
    Breviario, F
    Frank, R
    Muller, WA
    Hicklin, DJ
    Bohlen, P
    Dejana, E
    [J]. BLOOD, 2001, 97 (06) : 1679 - 1684
  • [10] Angiogenesis modulation in cancer research: Novel clinical approaches
    Cristofanilli, M
    Charnsangavej, C
    Hortobagyi, GN
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (06) : 415 - 426